Evidence map›Paper›PMID 36189975›Full record

ReviewAmerican journal of physiology. Cell physiology2022

Different modalities of host cell death and their impact on

Annuurun Nisa, Franciele C Kipper, Dipak Panigrahy, Sangeeta Tiwari, Andreas Kupz, Selvakumar Subbian

Open access · greenAbstract readReview
In one paragraph

Review in American journal of physiology. Cell physiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
9.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 87 citations in OpenAlex.

  1. Construction of RecombinantPathogens (Basel, Switzerland) · 2026
    Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Modulation of Ferroptosis During EarlybioRxiv : the preprint server for biology · 2026
    Article
  8. Article
  9. Review
  10. Identification ofInternational journal of chronic obstructive pulmonary disease · 2026
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Cell death pathways in response toInfection and immunity · 2025
    Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Annuurun NisaPublic Health Research Institute, New Jersey Medical School, Rutgers University, Newark, New Jersey.
Franciele C KipperCenter for Vascular Biology Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
Dipak PanigrahyCenter for Vascular Biology Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
Sangeeta TiwariDepartment of Biological Sciences, Border Biomedical Research Center (BBRC), University of Texas, El Paso, Texas.
Andreas KupzCentre for Molecular Therapeutics, Australian Institute of Tropical Health and Medicine (AITHM), James Cook University, Townsville, Queensland, Australia.
Selvakumar SubbianPublic Health Research Institute, New Jersey Medical School, Rutgers University, Newark, New Jersey.ORCID 0000-0003-2021-8632
Beth Israel Deaconess Medical Center · USRutgers, The State University of New Jersey · USAustralian Institute of Tropical Health and Medicine · AU

Funding

Optimizing vaccine science to improve the outcome of tuberculosis treatmentR01AI161822 · NIAID · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI SUBBIAN, SELVAKUMAR · 2021 to 2025
$3.2M
Development of Drugs to Target Arginine Biosythesis in Mycobacterium tuberculosisSC1GM140968 · NIGMS · UNIVERSITY OF TEXAS EL PASO · PI TIWARI, SANGEETA · 2021 to 2024
$1.5M
HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) R01AI161822NIAID NIH HHS R01 AI161822NIGMS NIH HHS SC1 GM140968
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Mycobacterium tuberculosisTuberculosisCell DeathGranulomaHost-Pathogen InteractionsHumansMacrophagescell death signalinggranulomahost-directed therapyimmune cellsinflammation

Identifiers

PMID36189975
PMCPMC9662802
OpenAlexW4300689404

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.